AAAAAA

   
Results: 1-25 |
Results: 25
HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART
Authors: Lucia, MB Rutella, S Leone, G Vella, S Cauda, R
Citation: Mb. Lucia et al., HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART, J ACQ IMM D, 27(4), 2001, pp. 321-330
Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study
Authors: De Luca, A Giancola, ML Ammassari, A Grisetti, S Cingolani, A Larussa, D Alba, L Murri, R Ippolito, G Cauda, R Monforte, AD Antinori, A
Citation: A. De Luca et al., Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study, J NEUROVIRO, 7(4), 2001, pp. 364-368
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: Epidemiological and clinical findings from a case-control study
Authors: Tacconelli, E Tumbarello, M Donati, KD Bettio, M Spanu, T Leone, F Sechi, LA Zanetti, S Fadda, G Cauda, R
Citation: E. Tacconelli et al., Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: Epidemiological and clinical findings from a case-control study, CLIN INF D, 33(10), 2001, pp. 1628-1635
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies
Authors: Tumbarello, M Tacconelli, E Donati, KD Bertagnolio, S Longo, B Ardito, F Fadda, G Cauda, R
Citation: M. Tumbarello et al., Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies, EUR J CL M, 20(7), 2001, pp. 498-501
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome
Authors: Tumbarello, M Tacconelli, E Donati, KD Bertagnolio, S Cataldo, M Pirronti, T Ardito, F Cauda, R
Citation: M. Tumbarello et al., Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome, EUR RESP J, 17(4), 2001, pp. 636-640
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
Authors: Antinori, A Cingolani, A Alba, L Ammassari, A Serraino, D Ciancio, BC Palmieri, F De Luca, A Larocca, LM Ruco, L Ippolito, G Cauda, R
Citation: A. Antinori et al., Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy, AIDS, 15(12), 2001, pp. 1483-1491
Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis
Authors: Matarrese, P Testa, U Cauda, R Vella, S Gambardella, L Malorni, W
Citation: P. Matarrese et al., Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis, BIOCHEM J, 355, 2001, pp. 587-595
HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era
Authors: Tumbarello, M Tacconelli, E Donati, KD Citton, R Leone, F Spanu, T Cauda, R
Citation: M. Tumbarello et al., HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era, J ACQ IMM D, 23(2), 2000, pp. 145-151
Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects
Authors: Donati, KD Bertagnolio, S Tumbarello, M Tacconelli, E Cataldo, M Longo, B Cauda, R
Citation: Kd. Donati et al., Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects, INT J ANT A, 16(3), 2000, pp. 357-360
Expression of the novel T cell activation molecule hpH4 in HIV-infected patients: Correlation with disease status
Authors: Lucia, MB Buonfiglio, D Bottarel, F Bensi, T Rutella, S Rumi, C Ortona, L Janeway, CA Cauda, R Dianzani, U
Citation: Mb. Lucia et al., Expression of the novel T cell activation molecule hpH4 in HIV-infected patients: Correlation with disease status, AIDS RES H, 16(6), 2000, pp. 549-557
Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals
Authors: Tumbarello, M Tacconelli, E Bertagnolio, S Cauda, R
Citation: M. Tumbarello et al., Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals, AIDS, 14(18), 2000, pp. 2948-2949
Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infection
Authors: Tacconelli, E Tumbarello, M Donati, KD Bertagnolio, S Pittiruti, M Leone, F Morace, G Cauda, R
Citation: E. Tacconelli et al., Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infection, J HOSP INF, 44(3), 2000, pp. 186-192
Central venous catheters and bloodstream infection
Authors: Tacconelli, E Tumbarello, M Cauda, R
Citation: E. Tacconelli et al., Central venous catheters and bloodstream infection, J AM MED A, 283(4), 2000, pp. 478-478
Oral thrush and HIV protease inhibitors - Authors' reply
Authors: Cauda, R Cassone, A
Citation: R. Cauda et A. Cassone, Oral thrush and HIV protease inhibitors - Authors' reply, J ACQ IMM D, 22(1), 1999, pp. 106-106
Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV-infection: A prospective case-control study
Authors: Cauda, R Tacconelli, E Tumbarello, M Morace, G De Bernardis, F Torosantucci, A Cassone, A
Citation: R. Cauda et al., Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV-infection: A prospective case-control study, J ACQ IMM D, 21(1), 1999, pp. 20-25
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy
Authors: Tumbarello, M Tacconelli, E Donati, KD Cauda, R
Citation: M. Tumbarello et al., HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy, J ACQ IMM D, 20(2), 1999, pp. 208-209
Non-AIDS-defining neoplasms and HIV infection
Authors: Ventura, G Tacconelli, E Tumbarello, M Lucia, MB Larocca, LM Cauda, R
Citation: G. Ventura et al., Non-AIDS-defining neoplasms and HIV infection, INT J MOL M, 4(6), 1999, pp. 639-643
Clostridium difficile-associated diarrhea in human immunodeficiency virus infection - A changing scenario
Authors: Tacconelli, E Tumbarello, M Donati, KD Leone, F Mazzella, P Cauda, R
Citation: E. Tacconelli et al., Clostridium difficile-associated diarrhea in human immunodeficiency virus infection - A changing scenario, CLIN INF D, 28(4), 1999, pp. 936-937
Candidemia in HIV-infected subjects
Authors: Tumbarello, M Tacconelli, E Donati, KD Morace, G Fadda, G Cauda, R
Citation: M. Tumbarello et al., Candidemia in HIV-infected subjects, EUR J CL M, 18(7), 1999, pp. 478-483
Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy
Authors: Cauda, R Lucia, MB Marasca, G Rutella, S Petrucci, MT La Verde, G Gastaldi, R
Citation: R. Cauda et al., Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy, EUR J HAEMA, 63(2), 1999, pp. 134-135
Induction of CD69 antigen on normal CD4(+) and CD8(+) lymphocyte subsets and its relationship with the phenotype of responding T-cells
Authors: Rutella, S Rumi, C Lucia, MB Barberi, T Puggioni, PL Lai, M Romano, A Cauda, R Leone, G
Citation: S. Rutella et al., Induction of CD69 antigen on normal CD4(+) and CD8(+) lymphocyte subsets and its relationship with the phenotype of responding T-cells, CYTOMETRY, 38(3), 1999, pp. 95-101
In vitro and in vivo anticandidal activity of human immunodeficiency virusprotease inhibitors
Authors: Cassone, A De Bernardis, F Torosantucci, A Tacconelli, E Tumbarello, M Cauda, R
Citation: A. Cassone et al., In vitro and in vivo anticandidal activity of human immunodeficiency virusprotease inhibitors, J INFEC DIS, 180(2), 1999, pp. 448-453
Characterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas
Authors: Buonfiglio, D Bragardo, M Bonissoni, S Redoglia, V Cauda, R Zupo, S Burgio, VL Wolff, H Franssila, K Gaidano, G Carbone, A Janeway, CA Dianzani, U
Citation: D. Buonfiglio et al., Characterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas, EUR J IMMUN, 29(9), 1999, pp. 2863-2874
Nosocomial bloodstream infections in HIV-infected patients: Attributable mortality and extension of hospital stay
Authors: Tumbarello, M Tacconelli, E Donati, KD Leone, F Morace, G Cauda, R Ortona, L
Citation: M. Tumbarello et al., Nosocomial bloodstream infections in HIV-infected patients: Attributable mortality and extension of hospital stay, J ACQ IMM D, 19(5), 1998, pp. 490-497
Staphylococcus aureus infections
Authors: Tacconelli, E Tumbarello, M Cauda, R
Citation: E. Tacconelli et al., Staphylococcus aureus infections, N ENG J MED, 339(27), 1998, pp. 2026-2026
Risultati: 1-25 |